Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2012

Mar 9, 2012

30071_dirs_2012-03-09_aec84f92-ee9e-4d54-b99a-6d4308e71065.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-03-07

Reporting Person: FARRELL PETER C (Director, Executive Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-07 ResMed Common Stock G 200000 Disposed 326959 Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 3317 Indirect
ResMed Common Stock 21391 Indirect
ResMed Common Stock 200000 Indirect
ResMed Common Stock 200000 Indirect
ResMed Common Stock 200000 Indirect
ResMed Common Stock 200000 Indirect

Footnotes

F1: Transaction represents a gift from the Peter C. Farrell Trust to fund the Peter C. Farrell February 2012 Annuity Trust. Dr. Farrell is the trustee of his personal trust, but is not the trustee of the Annuity Trust. Per the terms of the Annuity Trust, 90% of the original value will be transferred to Dr. Farrell at the end of the Trust's first year.